PreHevbrio was approved for the prevention of infection caused by all subtypes of hepatitis B virus in adults aged 18 years and older.
VBI Vaccines is recalling PreHevbrio and shutting down operations amid bankruptcy. Despite FDA approval in 2021, the ...
Months after filing for bankruptcy, VBI Vaccines is taking the next step in shuttering operations with the voluntarily ...
CAMBRIDGE, Mass., November 15, 2024--(BUSINESS WIRE)--VBI Vaccines Inc. (VBI) is initiating a voluntary nationwide recall of all remaining PreHevbrio ® [Hepatitis B Vaccine (Recombinant); NDC ...